UNSPSC 51191508: Triamterene

This classification denotes a potassium-sparing diuretic with the molecular formula C12H11N7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WS821Z52LQ, chemically known as 2,4,7-triamino-6-phenylpteridine but generally known as triamterene, which bears US NIH Compound Identifier 5546. European Medicines Agency schedules Triamterene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11256MIG. The term TRIAMTERENE is an International Non-Proprietary Name.

UNSPSC 51191508 Triamterene is a Commodity code that represents pharmaceutical products, though recent state and local procurement activity under this code involves both branded pharmaceutical supply and chemical commodities for municipal operations. The code encompasses generic multi-source pharmaceuticals and over-the-counter products distributed through state and local government health facilities, as well as chemical supply for water treatment and pollution control operations. Issuing bodies soliciting under this code include state multistate cooperative purchasing alliances administering pharmaceutical contracts across multiple jurisdictions, municipal governments procuring chemicals for water infrastructure, and participating state and local health facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant cooperative purchasing vehicle, with participating members across multiple states including Oregon. Insurance requirements vary by solicitation type: municipal chemical procurement typically requires General Liability and Auto Liability coverage in the $1,000,000 to $2,000,000 range, while pharmaceutical RFPs demand higher coverage such as $5,000,000 commercial general liability and $2,000,000 network security and privacy liability.

Recent activity spans Minnesota and Connecticut, with the most prominent opportunity being MMCAP's RFP for Generic Multi-Source Pharmaceuticals and Over the Counter Products (Solicitation S1070000015802), issued by the Minnesota Department of Administration with proposals due March 26, 2026 and awarded vendors effective July 1, 2026. The City of Meriden, Connecticut, issued an IFB for Sodium Bisulfite chemical supply (Solicitation B02715) due July 29, 2026, for the Water Pollution Control Facility. The MMCAP RFP requires vendors to supply products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with pricing weighted 75 percent on competitiveness, submission through the ePro procurement system, and compliance with cGMP and the Drug Supply Chain Security Act. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers and accept a 3 percent administrative fee on all contract purchases, with the contract term two years for new responders.